DNA methylation patterns of steroid receptor genes ESR1, ESR2 and PGR in deep endometriosis compromising the rectum

International Journal of Molecular Medicine

Volumn 33, Issue 4, 2014, Pages 897-904

  Meyer, Joana Ladeira ^a   Zimbardi, Daniela ^a   Podgaec, Sérgio ^b   Amorim, Renee Laufer ^a   Abrão, Maurício Simões ^b   Rainho, Cláudia Aparecida ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biomarkers; CpG island; DNA methylation; Endometriosis; Epigenetics; Steroid hormone receptors

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENOMIC DNA; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; DNA EXTRACTION; DNA METHYLATION; DYSMENORRHEA; DYSPAREUNIA; ENDOMETRIOSIS; FEMALE; FEMALE INFERTILITY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINAL DEEP ENDOMETRIOSIS; LAPAROSCOPY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREMENOPAUSE; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; DNA METHYLATION; ENDOMETRIOSIS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; RECEPTORS, PROGESTERONE; RECTUM;

EID: 84899516563     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1637     Document Type: Article

References (47)

1. Portela A and Esteller M: Epigenetic modifications and human disease. Nat Biotechnol 28: 1057-1068, 2010.
2. Ballestar E: An introduction to epigenetics. Adv Exp Med Biol 711: 1-11, 2011.
3. Illingworth RS and Bird AP: CpG islands - 'a rough guide'. FEBS Lett 583: 1713-1720, 2009.
4. Guo SW: Epigenetics of endometriosis. Mol Hum Reprod 15: 587-607, 2009.
5. Bulun SE: Endometriosis. N Engl J Med 360: 268-279, 2009.
6. Nasu K, Kawano Y, Tsukamoto Y, et al: Aberrant DNA methylation status of endometriosis: epigenetics as the pathogenesis, biomarker and therapeutic target. J Obstet Gynaecol Res 37: 683-695, 2011.
7. Martini M, Ciccarone M, Garganese G, et al: Possible involvement of hMLH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis. Int J Cancer 102: 398-406, 2002. (Pubitemid 35265880)
8. Wu Y, Halverson G, Basir Z, Strawn E, Yan P and Guo SW: Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis. Am J Obstet Gynecol 193: 371-380, 2005.
9. Wu Y, Strawn E, Basir Z, Halverson G and Guo SW: Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics 1: 106-111, 2006.
10. Xue Q, Lin Z, Cheng YH, et al: Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol Reprod 77: 681-687, 2007. (Pubitemid 47494383)
11. Xue Q, Lin Z, Yin P, et al: Transcriptional activation of steroidogenic factor-1 by hypomethylation of the 5′ CpG island in endometriosis. J Clin Endocrinol Metab 92: 3261-3267, 2007. (Pubitemid 47236401)
12. Wang D, Chen Q, Zhang C, Ren F and Li T: DNA hypomethylation of the COX-2 gene promoter is associated with up-regulation of its mRNA expression in eutopic endometrium of endometriosis. Eur J Med Res 17: 12, 2012.
13. Wu Y, Strawn E, Basir Z, Halverson G and Guo SW: Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis. Fertil Steril 87: 24-32, 2007. (Pubitemid 46013877)
14. Izawa M, Taniguchi F, Uegaki T, Takai E, Iwabe T, Terakawa N and Harada T: Demethylation of a nonpromoter cytosinephosphate-guanine island in the aromatase gene may cause the aberrant up-regulation in endometriotic tissues. Fertil Steril 95: 33-39, 2010.
15. Bulun SE, Cheng YH, Pavone ME, et al: Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. Semin Reprod Med 28: 36-43, 2010.
16. Grandien K: Determination of transcription start sites in the human estrogen receptor gene and identification of a novel, tissue-specific, estrogen receptor-mRNA isoform. Mol Cell Endocrinol 116: 207-212, 1996.
17. Grandien K, Berkenstam A and Gustafsson JA: The estrogen receptor gene: promoter organization and expression. Int J Biochem Cell Biol 29: 1343-1369, 1997. (Pubitemid 28153487)
18. Wen DX, Xu YF, Mais DE, Goldman ME and McDonnell DP: The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol Cell Biol 14: 8356-8364, 1994. (Pubitemid 24373584)
19. Hirata S, Shoda T, Kato J and Hoshi K: The multiple untranslated first exons system of the human estrogen receptor beta (ER beta) gene. J Steroid Biochem Mol Biol 78: 33-40, 2001. (Pubitemid 32791329)
20. Wills HJ, Reid GD, Cooper MJ and Morgan M: Fertility and pain outcomes following laparoscopic segmental bowel resection for colorectal endometriosis: a review. Aust NZ J Obstet Gynaecol 48: 292-295, 2008. (Pubitemid 351798372)
21. No authors listed: Revised American Society for Reproductive Medicine classification of endometriosis. Fertil Steril 67: 817-821, 1997.
22. Abrao MS, Neme RM, Carvalho FM, Aldrighi JM and Pinotti JA: Histological classification of endometriosis as a predictor of response to treatment. Int J Gynaecol Obstet 82: 31-40, 2003. (Pubitemid 36808590)
23. Pires AR, da Matta Andreiulo F and de Souza SR: TMA for all: a new method for the construction of tissue microarrays without recipient paraffin block using custom-built needles. Diagn Pathol 1: 14, 2006.
24. Negraes PD, Favaro FP, Camargo JL, Oliveira ML, Goldberg J, Rainho CA and Salvadori DM: DNA methylation patterns in bladder cancer and washing cell sediments: a perspective for tumor recurrence detection. BMC Cancer 8: 238, 2008.
25. Sasaki M, Tanaka Y, Perinchery G, Dharia A, Kotcherguina I, Fujimoto S and Dahiya R: Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer. J Natl Cancer Inst 94: 384-390, 2002. (Pubitemid 34257482)
26. Neve RM, Chin K, Fridlyand J, et al: A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10: 515-527, 2006. (Pubitemid 44854747)
27. Gu F, Doderer MS, Huang YW, et al: CMS: a web-based system for visualization and analysis of genome-wide methylation data of human cancers. PLoS One 8: e60980, 2013.
28. Dai D, Wolf DM, Litman ES, White MJ and Leslie KK: Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors. Cancer Res 62: 881-886, 2002. (Pubitemid 34126968)
29. Wu Y, Shi X and Guo SW: The knockdown of progesterone receptor isoform B (PR-B) promotes proliferation in immortalized endometrial stromal cells. Fertil Steril 90: 1320-1323, 2008.
30. Brandenberger AW, Lebovic DI, Tee MK, Ryan IP, Tseng JF, Jaffe RB and Taylor RN: Oestrogen receptor (ER)-alpha and ER-beta isoforms in normal endometrial and endometriosis-derived stromal cells. Mol Hum Reprod 5: 651-655, 1999. (Pubitemid 29317755)
31. Fujimoto J, Hirose R, Sakaguchi H and Tamaya T: Expression of oestrogen receptor-alpha and -beta in ovarian endometriomata. Mol Hum Reprod 8: 742-747, 1999. (Pubitemid 29366872)
32. Leader JE, Wang C, Popov VM, Fu M and Pestell RG: Epigenetics and the estrogen receptor. Ann NY Acad Sci 1089: 73-87, 2006. (Pubitemid 47092100)
33. Ström A, Hartman J, Foster JS, Kietz S, Wimalasena J and Gustafsson JA: Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci USA 101: 1566-1571, 2004. (Pubitemid 38236167)
34. Taylor SE, Martin-Hirsch PL and Martin FL: Oestrogen receptor splice variants in the pathogenesis of disease. Cancer Lett 288: 133-148, 2010.
35. Flouriot G, Griffin C, Kenealy M, Sonntag-Buck V and Gannon F: Differentially expressed messenger RNA isoforms of the human estrogen receptor-alpha gene are generated by alternative splicing and promoter usage. Mol Endocrinol 12: 1939-1954, 1998. (Pubitemid 28544188)
36. Lu B, Leygue E, Dotzlaw H, Murphy LJ, Murphy LC and Watson PH: Estrogen receptor-beta mRNA variants in human and murine tissues. Mol Cell Endocrinol 138: 199-203, 1998. (Pubitemid 28302030)
37. Lu B, Dotzlaw H, Leygue E, Murphy LJ, Watson PH and Murphy LC: Estrogen receptor-alpha mRNA variants in murine and human tissues. Mol Cell Endocrinol 158: 153-161, 1999.
38. Ottaviano YL, Issa JP, Parl FF, Smith HS, Baylin SB and Davidson NE: Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res 54: 2552-2555, 1994. (Pubitemid 24173735)
39. Lapidus RG, Nass SJ and Davidson NE: The loss of estrogen and progesterone receptor gene expression in human breast cancer. J Mammary Gland Biol Neoplasia 3: 85-94, 1998. (Pubitemid 128513222)
40. Sharma D, Saxena NK, Davidson NE and Vertino PM: Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes. Cancer Res 66: 6370-6378, 2006.
41. Macaluso M, Montanari M, Noto PB, Gregorio V, Bronner C and Giordano A: Epigenetic modulation of estrogen receptor-alpha by pRb family proteins: a novel mechanism in breast cancer. Cancer Res 67: 7731-7737, 2007. (Pubitemid 47281366)
42. Sharma D, Blum J, Yang X, Beaulieu N, Macleod AR and Davidson NE: Release of methyl CpG binding proteins and histone deacetylase 1 from the estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells. Mol Endocrinol 19: 1740-1751, 2005. (Pubitemid 41007887)
43. Rody A, Holtrich U, Solbach C, et al: Methylation of estrogen receptor beta promoter correlates with loss of ER-beta expression in mammary carcinoma and is an early indication marker in premalignant lesions. Endocr Relat Cancer 12: 903-916, 2005. (Pubitemid 41815784)
44. Zhao L, Yu Z, Li Y, et al: Clinical implications of ERβ methylation on sporadic breast cancers in Chinese women. Med Oncol 29: 1569-1575, 2012.
45. Han H, Cortez CC, Yang X, Nichols PW, Jones PA and Liang G: DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter. Hum Mol Genet 20: 4299-4310, 2011.
46. Zelenko Z, Aghajanova L, Irwin JC and Giudice LC: Nuclear receptor, coregulator signaling, and chromatin remodeling pathways suggest involvement of the epigenome in the steroid hormone response of endometrium and abnormalities in endometriosis. Reprod Sci 19: 152-162, 2012.
47. Laird PW: The power and the promise of DNA methylation markers. Nat Rev Cancer 3: 253-266, 2003.